Patents by Inventor Sudheer Dhanireddy

Sudheer Dhanireddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF HISTONE ACETYLTRANSFERASE INHIBITOR AMIDOXIMES AS ANTI-PROLIFERATIVE AGENTS
    Publication number: 20230381119
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of HAT malfunction related pathologies.
    Type: Application
    Filed: April 7, 2023
    Publication date: November 30, 2023
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe
  • Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents
    Patent number: 11648217
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of HAT malfunction related pathologies.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: May 16, 2023
    Assignee: Texas Woman's University
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe
  • USE OF HISTONE ACETYLTRANSFERASE INHIBITOR AMIDOXIMES FOR HISTONE ACETYLTRANSFERASE MALFUNCTION RELATED PATHOLOGY
    Publication number: 20210023028
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of HAT malfunction related pathologies.
    Type: Application
    Filed: August 31, 2020
    Publication date: January 28, 2021
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe
  • Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents
    Patent number: 10758501
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of cancer. In preferred embodiments, combinations of two or more bisamidoximes or combinations of a bisamidoxime and another anti-cancer agent were found to be effective against various types of cancer cells.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: September 1, 2020
    Assignee: Texas Woman's University
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe
  • USE OF HISTONE ACETYLTRANSFERASE INHIBITOR AMIDOXIMES AS ANTI-PROLIFERATIVE AGENTS
    Publication number: 20190167608
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of cancer. In preferred embodiments, combinations of two or more bisamidoximes or combinations of a bisamidoxime and another anti-cancer agent were found to be effective against various types of cancer cells.
    Type: Application
    Filed: October 2, 2018
    Publication date: June 6, 2019
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe